The fact that the low LAT1 expression group tended to have more positive margin status and distant metastases than patients in the high-expression group may contribute to the discrepancy between our data on the predictive value of LAT1, as these have shown to be poor prognostic factors in breast cancer [49, 50]. This evidence concerns the gene SLC7A5 and breast carcinoma.